Abstract
Aminophosphonic acids were almost unknown in 1959 but today they are the subject of more than 6000 papers. Their negligible mammalian toxicity, and the fact that they very efficiently mimic aminocarboxylic acids makes them extremely important antimetabolites, which compete with their carboxylic counterparts for the active sites of enzymes and other cell receptors. Although biological importance of these compounds was recognized over 50 years ago they still represent promising and somewhat undiscovered class of potential drugs.
Current Medicinal Chemistry - Anti-Cancer Agents
Title: Aminophosphonic Acids of Potential Medical Importance
Volume: 1 Issue: 3
Author(s): Pawel Kafarski and Barbara Lejczak
Affiliation:
Abstract: Aminophosphonic acids were almost unknown in 1959 but today they are the subject of more than 6000 papers. Their negligible mammalian toxicity, and the fact that they very efficiently mimic aminocarboxylic acids makes them extremely important antimetabolites, which compete with their carboxylic counterparts for the active sites of enzymes and other cell receptors. Although biological importance of these compounds was recognized over 50 years ago they still represent promising and somewhat undiscovered class of potential drugs.
Export Options
About this article
Cite this article as:
Kafarski Pawel and Lejczak Barbara, Aminophosphonic Acids of Potential Medical Importance, Current Medicinal Chemistry - Anti-Cancer Agents 2001; 1 (3) . https://dx.doi.org/10.2174/1568011013354543
| DOI https://dx.doi.org/10.2174/1568011013354543 |
Print ISSN 1568-0118 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-5968 |
Related Articles
-
Risk Assessment of the Use of Autonomous Parvovirus-Based Vectors
Current Gene Therapy Small Players With Big Roles: MicroRNAs as Targets to Inhibit Breast Cancer Progression
Current Drug Targets TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology
Current Pharmaceutical Biotechnology Discovering Tumor Suppressor Genes Through Genome-Wide Copy Number Analysis
Current Genomics In Vivo Cellular Imaging for Translational Medical Research
Current Medical Imaging Structure and Functions of T-cell Immunoglobulin-domain and Mucin- domain Protein 3 in Cancer
Current Medicinal Chemistry Antiangiogenic Therapy for High-Grade Gliomas
CNS & Neurological Disorders - Drug Targets Radionuclide Imaging in Drug Development
Current Pharmaceutical Design Diabetes Mellitus as a Risk Factor for Cancer: Stress or Viral Etiology?
Infectious Disorders - Drug Targets Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes
Current Pharmaceutical Design In Vivo Bio-imaging Using Chlorotoxin-based Conjugates
Current Pharmaceutical Design Biological and Toxicological Evaluation of N-(4methyl-phenyl)-4-methylphthalimide on Bone Cancer in Mice
Anti-Cancer Agents in Medicinal Chemistry Cancer-Associated Carbonic Anhydrases and Their Inhibition
Current Pharmaceutical Design GCPII Imaging and Cancer
Current Medicinal Chemistry Regulation of Angiogenesis by Th1- and Th2-Type Cytokines
Current Pharmaceutical Design ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry Environment-friendly Synthesis of Bioactive Pyrazoles
Current Organic Chemistry Recent Progress in the Development of Quinoline Derivatives for the Exploitation of Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Circulating Tumor Cells (CTCs) as a Liquid Biopsy Material and Drug Target
Current Drug Targets Extra-Hepatic Isozymes from the CYP1 and CYP2 Families as Potential Chemotherapeutic Targets
Current Topics in Medicinal Chemistry

